About SINCO PHARMA Company

As a leading marketing, promotion and channel management service provider, the Group draws on its rich experience in the distribution of imported pharmaceuticals, focuses on blood products, and provides comprehensive marketing, promotion and channel management services for overseas small and medium-sized pharmaceutical companies based on a marketing and promotion network covering the whole of China. The Group's products are imported from well-known overseas pharmaceutical companies, and the product portfolio mainly covers prescription drugs such as blood products and anti-infective drugs. The marketing and promotion services provided by the Group include: coordinating and cooperating with overseas pharmaceutical companies to carry out import registration/re-registration work and other matters required by regulatory authorities; formulating customized marketing and promotion strategies based on considerations of product treatment fields, product characteristics, regulatory environment, market needs and other commercial factors; selecting, appointing and managing third-party service promoters; organizing academic conferences, lectures, seminars and other promotional activities; and communicating the medical uses and benefits of the Group's products to physicians. Channel management services provided by the Group include: product customs clearance and inspection; cooperation with third parties to carry out logistics distribution work; participation in tenders; confirmation of purchase orders, product delivery and receipt work of third party commercial pharmaceutical distribution companies; collection and analysis of sales data; and management and improvement of inventory in commercial distribution channels. The Group selects high-quality blood products from overseas markets to make up for unmet pharmaceutical needs in the domestic market; and ensures that these products have strong growth potential in the Chinese pharmaceutical industry by virtue of their excellent clinical effects. The Group continues to expand the medical and aesthetic industry layout, and the existing medical and aesthetic product research and development projects are progressing steadily. The Group's R&D will continue the concept of “safe, effective and reliable”. While launching new products with high quality, it will continue to enrich product pipelines and fields to provide customers with more choices.